ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BDSX Biodesix Inc

1.40
0.09 (6.87%)
May 03 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 151,010
Bid Price 1.31
Ask Price 1.40
News -
Day High 1.40

Low
1.03

52 Week Range

High
2.21

Day Low 1.31
Share Name Share Symbol Market Stock Type
Biodesix Inc BDSX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.09 6.87% 1.40 16:07:26
Open Price Low Price High Price Close Price Previous Close
1.33 1.31 1.40 1.40 1.31
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
1,062 151,010 US$ 1.34 US$ 202,106 - 1.03 - 2.21
Last Trade Type Quantity Price Currency
17:11:29 1 US$ 1.40 USD

Biodesix Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
135.72M 96.94M - 49.09M -52.15M -0.54 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Biodesix News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BDSX Message Board. Create One! See More Posts on BDSX Message Board See More Message Board Posts

Historical BDSX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.241.401.211.2631,4660.1612.90%
1 Month1.271.521.151.35241,6410.1310.24%
3 Months1.982.031.151.43139,507-0.58-29.29%
6 Months1.472.211.151.61121,513-0.07-4.76%
1 Year1.682.211.031.5598,039-0.28-16.67%
3 Years16.2816.41490.9553.12165,917-14.88-91.40%
5 Years13.5931.990.9555.08163,179-12.19-89.70%

Biodesix Description

Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Your Recent History

Delayed Upgrade Clock